Single-Dose Tranexamic Acid Reduces Postoperative Bleeding After Coronary Surgery in Patients Treated with Aspirin Until Surgery

Tranexamic acid reduces postoperative bleeding after coronary artery bypass grafting. We evaluated the effects of a single dose of tranexamic acid given immediately before cardiopulmonary bypass (CPB) in patients treated with aspirin until the day before surgery. The study was a prospective, randomized, double-blinded, placebo-controlled, parallel-group trial. Eighty patients were included and divided into two groups: one group received tranexamic acid 30 mg/kg, and one group received placebo (0.9% NaCl) as a bolus injection before CPB. Postoperative blood loss was recorded for 16 h. Transfusions of blood products were recorded for the whole hospital stay. Transfusions of packed red cells were given when the hematocrit value was less than 20% during CPB and less than 25% after surgery. The patients in the tranexamic acid group had significantly less postoperative bleeding compared with the patients in the placebo group (mean [sd]) (475 [274] mL versus 713 [243] mL;P < 0.001). An effective inhibition of fibrinolysis was found in patients receiving tranexamic acid. Tranexamic acid reduces postoperative bleeding in coronary artery bypass grafting patients treated with aspirin until the day before surgery.

[1]  M. Ruel,et al.  Is tranexamic acid safe in patients undergoing coronary endarterectomy? , 2001, The Annals of thoracic surgery.

[2]  W. Weightman,et al.  The effects of recent aspirin ingestion on platelet function in cardiac surgical patients. , 2001, Journal of cardiothoracic and vascular anesthesia.

[3]  O. Alfieri,et al.  Tranexamic Acid Administration after Cardiac Surgery: A Prospective, Randomized, Double-blind, Placebo-controlled Study , 2001, Anesthesiology.

[4]  S. Shapiro,et al.  Epidemiological assessment of drug-induced disease , 2000, The Lancet.

[5]  O. Alfieri,et al.  Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. , 2000, The Journal of thoracic and cardiovascular surgery.

[6]  M. Prins,et al.  Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.

[7]  G. Gravlee,et al.  Anticoagulation Monitoring during Cardiac Surgery , 1999 .

[8]  G. Gravlee,et al.  Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. , 1999, Anesthesiology.

[9]  D. Birnbaum,et al.  Are In-Vitro Platelet Function Tests Useful in Predicting Blood Loss Following Open Heart Surgery? , 1998, The Thoracic and cardiovascular surgeon.

[10]  P. Mongan,et al.  Tranexamic Acid and Aprotinin Reduce Postoperative Bleeding and Transfusions During Primary Coronary Revascularization , 1998, Anesthesia and analgesia.

[11]  G. Schmitz,et al.  Predictors of blood loss after coronary artery bypass grafting. , 1997, Journal of cardiothoracic and vascular anesthesia.

[12]  A. Laupacis,et al.  Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery: Meta-Analyses Using Perioperative Blood Transfusion As the Outcome , 1997, Anesthesia and analgesia.

[13]  P. Mongan,et al.  Tranexamic Acid Is Effective in Decreasing Postoperative Bleeding and Transfusions in Primary Coronary Artery Bypass Operations: A Double-Blind, Randomized, Placebo-Controlled Trial , 1997, Anesthesia and analgesia.

[14]  G. Gravlee,et al.  Tranexamic Acid Reduces Bleeding After Cardiopulmonary Bypass When Compared to Epsilon Aminocaproic Acid and Placebo , 1997, Journal of cardiac surgery.

[15]  J L Cox,et al.  Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. , 1996, The Journal of thoracic and cardiovascular surgery.

[16]  J. Carroll,et al.  Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial. , 1995, The Journal of thoracic and cardiovascular surgery.

[17]  T. Treasure,et al.  Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. , 1995, The Annals of thoracic surgery.

[18]  D. Rijken,et al.  Interaction of Plasminogen Activators and Plasminogen with Heparin: Effect of Ionic Strength , 1993, Thrombosis and Haemostasis.

[19]  J. Loscalzo,et al.  Reciprocating autocatalytic interactions between platelets and the activation system. , 1993, Thrombosis research.

[20]  S. Khuri,et al.  Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. , 1992, The Journal of thoracic and cardiovascular surgery.

[21]  D. Taggart,et al.  Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements , 1991 .

[22]  D. Wheatley,et al.  Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. , 1990, The Annals of thoracic surgery.

[23]  A.,et al.  Bleeding Complications Associated With Cardiopulmonary Bypass , 2003 .

[24]  J. Birkmeyer,et al.  Reexploration for Hemorrhage Following Coronary Artery Bypass GraftingIncidence and Risk Factors , 2000 .

[25]  M. Abdelnoor,et al.  Tranexamic acid (Cyklokapron) is not necessary to reduce blood loss after coronary artery bypass operations. , 1993, The Journal of thoracic and cardiovascular surgery.

[26]  I. Goel,et al.  Prophylactic tranexamic acid decreases bleeding after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.